Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Uk Mhra Gmp
  6. /
  7. APTUIT (OXFORD) LIMITED
Uk Mhra Gmp
•APTUIT (OXFORD) LIMITED•February 24, 2026

APTUIT (OXFORD) LIMITED – UK MHRA GMP Certificate UK API 40699 Insp GMP 40699/839548-0011

Record Details

This Uk Mhra Gmp record concerns APTUIT (OXFORD) LIMITED, with an inspection on February 24, 2026, issued by the MHRA, covering drugs.

Company
APTUIT (OXFORD) LIMITED
Compliance status
GMPC
Certificate type
GMP
Inspection date
February 24, 2026
Issued
April 20, 2026
MIA number
UK API 40699
Site address
150 BROOK DRIVE, MILTON PARK, ABINGDON, OX14 4SD, UNITED KINGDOM
Country
UNITED KINGDOM
Products
Human Medicinal Products
Manufacturing operations
[2000006383] FROVATRIPTAN SUCCINATE [1000002302] FENFLURAMINE [1000015396] PLERIXAFOR Active Substances 3. MANUFACTURING OPERATIONS - ACTIVE SUBSTANCES FROVATRIPTAN SUCCINATE 3.1 Manufacture of Active Substance by Chemical Synthesis 3.1.1  Manufacture Of Active Substance Intermediates 3.1.2  Manufacture Of Crude Active Substance 3.1.3  Salt Formation/Purification steps (eg. Crystallisation) Salt formation and crystalisation then drying 3.5 General Finishing Steps 3.5.2  Primary Packaging 3.5.3  Secondary Packaging FENFLURAMINE 3.1 Manufacture of Active Substance by Chemical Synthesis 3.1.1  Manufacture Of Active Substance Intermediates 3.1.2  Manufacture Of Crude Active Substance 3.1.3  Salt Formation/Purification steps (eg. Crystallisation) Chloride salt formation followed by purification by crystallisation. 3.5 General Finishing Steps 3.5.1  Physical Processing Steps Drying 3.5.2  Primary Packaging 3.5.3  Secondary Packaging 3.6 Quality Control Testing 3.6.1  Physical / Chemical testing PLERIXAFOR 3.1 Manufacture of Active Substance by Chemical Synthesis 3.1.1  Manufacture Of Active Substance Intermediates 3.1.2  Manufacture Of Crude Active Substance 3.1.3  Salt Formation/Purification steps (eg. Crystallisation) FINAL STEP INVOLVES CRYSTALLISATION 3.5 General Finishing Steps 3.5.1  Physical Processing Steps MANUFACTURE INVOLVES DRYING 3.5.2  Primary Packaging 3.5.3  Secondary Packaging
View Company Profile

ID · deca470c-8258-4543-8f19-7b5385d47bde

Other documents for APTUIT (OXFORD) LIMITED
  • 483 - 2025-08-22August 22, 2025
  • 483 - 2016-07-22July 22, 2016

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore APTUIT (OXFORD) LIMITED
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.